Effect of Comprehensive Treatment for Aggressive Retinopathy of Prematurity

Siqi WU; Gang CHEN; Yishuang XIAO

doi:10.12259/j.issn.2095-610X.S20220513

Volume 43 Issue 5

May 2022

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2022 > 43(5): 127-132

Siqi WU, Gang CHEN, Yishuang XIAO. Effect of Comprehensive Treatment for Aggressive Retinopathy of Prematurity[J]. Journal of Kunming Medical University, 2022, 43(5): 127-132. doi: 10.12259/j.issn.2095-610X.S20220513

Citation:

Siqi WU, Gang CHEN, Yishuang XIAO. Effect of Comprehensive Treatment for Aggressive Retinopathy of Prematurity[J]. Journal of Kunming Medical University, 2022, 43(5): 127-132. doi: 10.12259/j.issn.2095-610X.S20220513

Citation:

PDF( 1174 KB)

Effect of Comprehensive Treatment for Aggressive Retinopathy of Prematurity

doi: 10.12259/j.issn.2095-610X.S20220513

1.
Dept. of Ophthalmology, Kunming Children’s Hospital, Kunming Yunnan 650034
2.
Dept. of Ophthalmology, Dali Maternal and Child Health Hospital, Dali Yunnan 671000, China

Received Date: 2022-01-11
Available Online: 2022-05-19
Publish Date: 2022-05-27

Abstract

Abstract

Objective To observe the effect of treatment for aggressive posterior retinopathy of prematurity （A-ROP）. Methods Retrospective case studies were made and 55 premature infants （110 eyes） who were diagnosed as A-ROP were selected from Kunming Children’s Hospital from July 2015 to May 2020, including 35 females and 20 males. The gestational age ranged from 24 to 37 （29.47±2.30） weeks and the birth weight ranged from 730 to 2250 （1322.09±322.75） g.All children received intravitreous injection of ranibizumb 10 mg/ml 0.03 ml （IVR） within 48 hours after the diagnosis. After IVR, the systemic and ocular adverse effects were observed during the follow-up and checked the retina after 1 week, 2 weeks, 1 month, 3 months, 6 months and 1 year for six times. Retinal Laser photocoagulation （LP） therapy was given to those recurrent eyes or not responding to ranibizumb. The time from IVR to LP were 26～48 （36.58±5.59） days. The effectiveness of IVP and the LP after IVR were divided into two groups to compare the gestational age, maternal age, length of NICU hospital stay, birth weight and the duration of oxygen inhalation, and compared the differences by t-test. Results 47.3% of eyes （52 eyes of 110 ） after IVR were effective, the lesions completely subsided, the additional lesions disappeared, and there was no neovascularization. The retinal vessels developed to zone 3. 57 eyes （51.8%） were treated with supplementary retinal LP. After IVR combined with LP, 1 eye （0.9%） had the recurrence, cataract combined with partial retinal detachment, vitrectomy and lensectomy were performed, and the retina was completely restored after the surgery. No ocular or systemic adverse reactions occurred in all pantients during the follow-up. Conclusion The comprehensive treatment of IVR and LP in A-ROP is effective.
- Aggressive posterior retinopathy of prematurity,
- Ranibizumb,
- Intravitreous injection,
- Laser photocoagulation

FullText(HTML)

References(25)

References

[1]	尹虹,黎晓新,姜燕荣,等. 极低体重早产儿视网膜病变的临床研究[J]. 中华眼底病杂志,2005,21(5):275-277. doi: 10.3760/j.issn:1005-1015.2005.05.002
[2]	尹虹,黎晓新. 与早产儿视网膜病变自然退行有关因素的分析[J]. 中华实验眼科杂志,2006,24(6):643-646. doi: 10.3760/cma.j.issn.2095-0160.2006.06.021
[3]	中华医学会眼科学会分会眼底病组. 中国早产儿视网膜病变筛查指南[J]. 中华眼科杂志,2014,50(12):933-935. doi: 10.3760/cma.j.issn.0412-4081.2014.12.017
[4]	None. The international of retinopathy of prematurity revisited[J]. Arch Ophthalmol,2005,123(7):991-999. doi: 10.1001/archopht.123.7.991
[5]	刘文. 早产儿视网膜病变[J]. 临床眼底病,2015,2(1):355.
[6]	Chiang M F,Quinn G E,Fielder A R,et al. International classification of retinopathy of prematurity,third edition[J]. Ophthalmology,2021,128(10):e51-e68. doi: 10.1016/j.ophtha.2021.05.031
[7]	陈锋,项道满,王建勋,等. 玻璃体注射Bevacizumab治疗阈值期早产儿视网膜病变的疗效分析[J]. 中国斜视与小儿眼科杂志,2016,24(2):25-28. doi: 10.3969/J.ISSN.1005-328X.2016.02.008
[8]	陈锋,项道满,王建勋,等. 不同剂量Bevacizumab治疗阈值前期I型早产儿视网膜病变的疗效分析[J]. 中国斜视与小儿眼科杂志,2018,26(4):25-26.
[9]	Chan-Ling T,Gock B,Stone J. The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia’ is the stimulus for normal retinal vasculogenesis[J]. Investigative Ophthalmology & Visual Science,1995,36(7):1201-14.
[10]	Zhang, G , Yang, M , Zeng, J , et al. （2017）. Comparison of intravitreal injection of ranibizumab versus laser therapy for zone ii treatment-requiring retinopathy of prematurity[J]. Retina, 37（4）: 710-717.
[11]	Zehetner C,Kirchmair R,Huber S,et al. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab,ranibizumab and pegaptanib in patients with age-related macular degeneration,and in patients with diabetic macular odema[J]. Br J Ophthalmol,2013,97(4):454-459. doi: 10.1136/bjophthalmol-2012-302451
[12]	Fierson W M,American Academy of Pediatrics Section on Ophthalmology,American Academy of Ophthalmology,et al. Screening examination of premature infants for retinopathy of prematurity[J]. Pediatrics,2013,131(1):189-195. doi: 10.1542/peds.2012-2996
[13]	Feng J,Qian J,Jiang Y,et al. Efficacy of primary intravitreal ranibizumab for retinopathy of prematurity in China[J]. Ophthalmology,2017,124(3):408-409. doi: 10.1016/j.ophtha.2016.10.032
[14]	Morin J,Luu T M,Superstein R,et al. Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity[J]. Pediatrics,2016,137(4):2015-3218.
[15]	赵欢欢,李静,穆歌,等. 玻璃体腔注射雷珠单抗治疗早产儿视网膜病变的临床疗效[J]. 中国斜视与小儿眼科杂志,2018,26(3):22-25.
[16]	Björn C Harder,Schlichtenbrede F C,Baltz S V,et al. Intravitreal bevacizumab for retinopathy of prematurity:Refractive error results.[J]. American Journal of Ophthalmology,2013,155(6):1119-1124. doi: 10.1016/j.ajo.2013.01.014
[17]	Geloneck M M,Chuang A Z,Clark W L,et al. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment a randomized clinical trial[J]. Jama Ophthalmology,2014,132(11):1327-1333. doi: 10.1001/jamaophthalmol.2014.2772
[18]	Gaurav,Sanghi,Mangat,et al. Aggressive posterior retinopathy of prematurity in Asian Indian babies:Spectrum of disease and outcome after laser treatment.[J]. Retina,2009,29(9):1335-1339. doi: 10.1097/IAE.0b013e3181a68f3a
[19]	Mintz-Hittner H A,Kennedy K A,Chuang A Z. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity[J]. New England Journal of Medicine,2011,364(7):603-615. doi: 10.1056/NEJMoa1007374
[20]	Mutlu F M,Sarici S U. Treatment of retinopathy of prematurity:A review of conventional and promising new therapeutic options.[J]. International Journal of Ophthalmology,2013,6(2):228-236.
[21]	Hwang C K,Hubbard G B,Hutchinson A K,et al. Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity:A 5-year retrospective analysis[J]. Ophthalmology,2015,122(5):1008-1015. doi: 10.1016/j.ophtha.2014.12.017
[22]	Hsieh C J,Liu J W,Huang J S,et al. Refractive outcome of premature infants with or without retinopathy of prematurity at 2 years of age:A prospective controlled cohort study[J]. The Kaohsiung journal of medical ences,2012,28(4):204-211. doi: 10.1016/j.kjms.2011.10.010
[23]	朱苾丹,李绍军. 我国早产儿视网膜病变筛查及治疗现状[J]. 中国斜视与小儿眼科杂志,2019,27(3):44-47. doi: 10.3969/J.ISSN.1005-328X.2019.03.016
[24]	曹贺,罗小玲,李志光,等. 激光光凝联合玻璃体腔注射低剂量雷珠单抗治疗急进型后极部ROP的疗效[J]. 国际眼科杂志,2019,19(11):1978-1981. doi: 10.3980/j.issn.1672-5123.2019.11.38
[25]	张国明,赵金凤. 重视儿童视网膜疾病的规范化治疗,努力提高其治疗水平[J]. 中华眼底病杂志,2020,36(8):583-589. doi: 10.3760/cma.j.cn511434-20200806-00380

Relative Articles(20)

Relative Articles

[1]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2025, 46(4): 1-9.
[2]	Hanyu ZHANG, Juan LUO, Mingzhi DONG, Qiyin CHEN, Fengrui ZHANG, Rui GUO, Junying TONG, Yinglei MIAO. Retrospective Cohort Study of Infliximab and Vederizumab in the Treatment of Moderate-to-severe Ulcerative Colitis. Journal of Kunming Medical University, 2024, 45(10): 36-44. doi: 10.12259/j.issn.2095-610X.S20241006
[3]	Ya LUO, Yanting YU, Xue ZHANG, Zhongjuan WANG. A Meta-analysis of the Risk of Secondary Infection of Tocilizumab in the Treatment of COVID-19. Journal of Kunming Medical University, 2024, 45(2): 57-64. doi: 10.12259/j.issn.2095-610X.S20240208
[4]	Shuang FANG, Libo ZHU, Ling LIU, Yanhua XU, Xue HU. Meta-analysis of the Impact of Early Enteral Nutrition on the Clinical Outcomes of Very Low Birth Weight Premature Infants. Journal of Kunming Medical University, 2024, 45(9): 129-135. doi: 10.12259/j.issn.2095-610X.S20240920
[5]	Siqi WU, Gang CHEN, Yishuang XIAO. The Correlation between Routine Blood Indicators and Severity of Retinopathy of Prematurity. Journal of Kunming Medical University, 2024, 45(5): 130-135. doi: 10.12259/j.issn.2095-610X.S20240520
[6]	Ziwei LI, Meiqun GU, Xiaozhi XU, Lianfang TANG, Xiaoyan XU, Jinghui YANG, Kai BI, Hongying MI. Clinical Data Analysis of 101 Cases of Very Preterm Infants. Journal of Kunming Medical University, 2022, 43(6): 85-91. doi: 10.12259/j.issn.2095-610X.S20220610
[7]	Jiarong YUAN, Ying LIANG, Jian MA, Chao QI, Nan LI. Effect of Early Physical Instruction on Development of Preterm Infants. Journal of Kunming Medical University, 2022, 43(3): 103-107. doi: 10.12259/j.issn.2095-610X.S20220323
[8]	Jian ZHAO, Jiubing XIE, Liankai ZHAO. Effects of Ranibizumab and Odix on the Microvascular Structure of the Macular Region. Journal of Kunming Medical University, 2022, 43(9): 141-146. doi: 10.12259/j.issn.2095-610X.S20220930
[9]	Zhou Yu E , Yin Li Juan , Yang Hui Bo . . Journal of Kunming Medical University, 2020, 41(02): 168-170.
[10]	Wang Jin Rui , Yang Ying . . Journal of Kunming Medical University, 2019, 40(04): 131-135.
[11]	Zhou Yu E , Zhang Zheng Ming , Liao Gui . The Clinic Effect of 2-Hour Feeding in Premature Infants with Very Low Birth Weight. Journal of Kunming Medical University, 2018, 39(08): 145-148.
[12]	Zhou Yu E , Yang Zhao Yu , Yin Yan Tao . Effect of Continuous Nursing on Extremely Low Birth Weight Preterm infants Infants. Journal of Kunming Medical University, 2018, 39(03): 137-140.
[13]	Liu Jing . Effect of Early Intervention in Neurodevelopment on Motor and Cognitive Development of High Risk Premature Infants. Journal of Kunming Medical University,
[14]	Huang Fu Chang Tao . Clinical Efficacy of 23-Gauge Transconjunctival Sutureless Vitrectomy for Vitreous Hemorrhage. Journal of Kunming Medical University,
[15]	Xiong Han Mei . . Journal of Kunming Medical University,
[16]	Zhu Zhao . . Journal of Kunming Medical University,
[17]	Chen Xian Yu . . Journal of Kunming Medical University,
[18]	. Comparison of the Clinical Characteristics of Newborn Respiratory Distress Syndrome between Full-term and Premature Infants. Journal of Kunming Medical University,
[19]	Zhang Yi . . Journal of Kunming Medical University,
[20]	. . Journal of Kunming Medical University,